gland pharma glp-1 manufacturing capacity Q4 net profit slips 3% as US sales moderate; focus shifts to complex injectables, CDMO growth Gland Pharma reported a strong
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




























